• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Vaccination and Medical Advancements Helping to Decrease Recurrent Respiratory Papillomatosis Incidence

by Linda Kossoff • April 20, 2021

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

What is the current status of recurrent respiratory papillomatosis (RRP) with regard to epidemiology, prevention, and treatment?

BOTTOM LINE

You Might Also Like

  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High
  • Adjuvant Therapies May Increase Time Between Surgeries for Recurrent Respiratory Papillomatosis
  • Adult-Onset Recurrent Respiratory Papillomatosis May Be Associated with Number of Sexual Partners
  • Laryngeal Distribution of Recurrent Respiratory Papillomatosis
Explore This Issue
April 2021

RRP continues to decline since the implementation of the human papilloma virus (HPV) vaccination, and advancements show promise in RRP medical management.

BACKGROUND: A rare benign neoplasm of the larynx affecting children and adults, RRP is caused by HPV infection. It presents as wart-like growths in the airway, is highly recurrent, and can significantly reduce quality of life. However, HPV research and vaccination, and an improved understanding of RRP, is changing the picture.

STUDY DESIGN: Retrospective review.

SETTING: Department of Otolaryngology–Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Va.

SYNOPSIS: In this retrospective review, researchers noted that the HPV vaccination has had a profound effect on the incidence of RRP and cited the findings of a five-year report using data from pediatric otolaryngologists in Australia, where the vaccination rate is high and RRP incidence was significantly decreased following vaccination implementation. They also pointed to recent case studies that suggest a potential role for the HPV-9 (Gardisil) vaccine as a therapy for RRP, and promising experimental trials using HPV DNA vaccines. Authors discussed the recent expansion in adjuvant medical treatment options for patients with severe RRP, including targeted therapies via immune modulation, which, with the advent of monoclonal antibodies, have become a mainstay of new drug development and application. One such treatment is bevacizumab, which, used intravenously, targets one of RRP’s pathologic pathways via vascular endothelial growth factor. The review also acknowledges the particular risk patients with RRP face during the COVID-19 pandemic due to their frequent need for operative interventions. Based on all current data examined, authors predicted a continued decrease in incidence of RRP and even a potential eradication of the disease.

CITATION: Benedict JJ, Derkay CS. Recurrent respiratory papillomatosis: A 2020 perspective [published online ahead of print March 13, 2021]. Laryngoscope Investig Otolaryngol. doi:10.1002/lio2.545.

Filed Under: Laryngology, Laryngology, Literature Reviews, Practice Focus Tagged With: clinical outcomes, treatmentIssue: April 2021

You Might Also Like:

  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High
  • Adjuvant Therapies May Increase Time Between Surgeries for Recurrent Respiratory Papillomatosis
  • Adult-Onset Recurrent Respiratory Papillomatosis May Be Associated with Number of Sexual Partners
  • Laryngeal Distribution of Recurrent Respiratory Papillomatosis

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939